Related Experiment Video
Updated: Jan 18, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
The Relationship Between the CHA2DS2-VASc Score and Lesion Complexity and Long-Term Outcomes in Peripheral Arterial
Ali Evsen1, Adem Aktan2, Raif Kılıç2
1Department of Cardiology, Dağkapı State Hospital, Diyarbakır, Turkiye.
Insights
The CHA2DS2-VASc score predicts lesion severity and long-term survival in peripheral artery disease (PAD) patients. Higher scores indicate increased risk for PAD complications and mortality.
Area of Science:
- Cardiology
- Vascular Medicine
- Medical Prognostics
Background:
- The CHA2DS2-VASc score, initially for atrial fibrillation stroke risk, is now used for broader cardiovascular prognostication.
- Peripheral artery disease (PAD) significantly impacts patient morbidity and mortality.
- Evaluating predictive tools for PAD outcomes is crucial for patient management.
Purpose of the Study:
- To assess the CHA2DS2-VASc score's predictive capability for lesion severity in PAD patients.
- To determine the association between the CHA2DS2-VASc score and long-term survival outcomes in PAD.
- To explore the utility of a widely used cardiovascular risk score in a different vascular disease context.
Main Methods:
- Retrospective analysis of 784 PAD patients diagnosed via CT angiography.
- Calculation of CHA2DS2-VASc scores for all participants.
- Assessment of lesion severity using TASC II criteria and categorization into simple (TASC-AB) and complex (TASC-CD) groups.
- Long-term mortality data collected from hospital and social security records.
Main Results:
- CHA2DS2-VASc score and left ventricular ejection fraction were independent predictors of lesion severity (P < 0.007 and P = 0.009, respectively).
- A CHA2DS2-VASc score threshold of 3.5 predicted long-term mortality with 70% sensitivity and 79% specificity (P < 0.001).
- Kaplan-Meier analysis revealed significantly lower survival rates in patients with higher CHA2DS2-VASc scores over 60 months (P < 0.001).
Conclusions:
- The CHA2DS2-VASc score is an independent predictor of lesion severity in PAD.
- Higher CHA2DS2-VASc scores are associated with adverse long-term outcomes and reduced survival in PAD patients.
- The CHA2DS2-VASc score demonstrates prognostic value beyond its original indication, extending to peripheral artery disease.
Objective:
Originally designed to evaluate stroke risk in individuals with atrial fibrillation unrelated to valvular disease, the CHA2DS2-VASc score (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, prior Stroke/transient ischemic attack/systemic embolism, Vascular disease, Age 65-74 years, and Sex category - female) is now additionally utilized for the prognostic evaluation of cardiovascular diseases. This study aimed to evaluate the predictive role of the CHA2DS2-VASc score for lesion severity and long-term survival outcomes in individuals with peripheral artery disease (PAD).
Method:
This retrospective analysis included 784 patients diagnosed with PAD via computed tomography (CT) angiography, consecutively enrolled from two medical centers. The CHA2DS2-VASc score was determined for all participants. Lesion severity was assessed according to the TASC II (Trans-Atlantic Inter-Society Consensus II) criteria, and patients were categorized into TASC-AB (simple) and TASC-CD (complex) lesion groups. Mortality data were obtained from hospital and social security records.
Results:
The study included 784 patients (average age: 61.7 +- 9.9 years; 17.2% female). In the regression analysis performed to predict lesion severity, we found that the CHA2DS2-VASc score (P < 0.007) and left ventricular ejection fraction (P = 0.009) were independent predictors. The receiver operating characteristic (ROC) curve indicated that a CHA2DS2-VASc score threshold of 3.5 predicted long-term mortality with 70% sensitivity and 79% specificity (P < 0.001). Kaplan-Meier survival estimates indicated that patients with higher CHA2DS2-VASc scores had significantly lower survival rates over the 60-month follow-up period (P < 0.001).
Conclusion:
The CHA2DS2-VASc score was independently associated with both lesion severity and adverse long-term outcomes in individuals with PAD.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests